(Q40127670)

17 September 2017

title

Four cardiac hormones eliminate up to 82% of human medullary thyroid carcinoma cells within 24 hours (English)

1 reference

17 September 2017

1 reference

Ehrentraud J Eichelbaum

1

1 reference

17 September 2017

Brian A Vesely

2

1 reference

17 September 2017

Abdel A Alli

3

1 reference

17 September 2017

Ying Sun

4

1 reference

17 September 2017

William R Gower

5

1 reference

17 September 2017

David L Vesely

6

1 reference

17 September 2017

publication date

1 December 2006

1 reference

17 September 2017

1 reference

17 September 2017

volume

30

1 reference

17 September 2017

issue

3

1 reference

17 September 2017

page(s)

325-332

1 reference

https://scigraph.springernature.com/pub.10.1007/s12020-006-0011-6

17 September 2017

exact match

0 references

cites work

Somatostatin analogs in the treatment of medullary thyroid carcinoma

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS12020-006-0011-6

Vessel dilator enhances sodium and water excretion and has beneficial hemodynamic effects in persons with congestive heart failure.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS12020-006-0011-6

Comparative Histopathologic, Histochemical, Electron Microscopic and Tissue Culture Studies of Bronchial Carcinoids and Oat Cell Carcinomas of Lung

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS12020-006-0011-6

Prognostic factors for thyroid carcinoma. A population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973-1991.

21 January 2018

1 reference

12 December 2020

Vessel dilator and kaliuretic peptide inhibit ERK 1/2 activation in human prostate cancer cells

1 reference

12 December 2020

Surgical strategy for the treatment of medullary thyroid carcinoma

1 reference

12 December 2020

Three peptides from the atrial natriuretic factor prohormone amino terminus lower blood pressure and produce diuresis, natriuresis, and/or kaliuresis in humans

1 reference

12 December 2020

N-terminal fragments of the proatrial natriuretic peptide in patients before and after hemodialysis treatment

1 reference

12 December 2020

Somatostatin production by a human medullary thyroid carcinoma cell line

1 reference

12 December 2020

Cancer statistics, 2005

1 reference

12 December 2020

Increased release of the N-terminal and C-terminal portions of the prohormone of atrial natriuretic factor during immersion-induced central hypervolemia in normal humans

1 reference

12 December 2020

Adrenomedullin, endothelin, neuropeptide Y, atrial, brain, and C-natriuretic prohormone peptides compared as early heart failure indicators.

1 reference

12 December 2020

Medullary carcinoma of the thyroid. A study of the clinical features and prognostic factors in 161 patients

1 reference

12 December 2020

Vessel dilator: most potent of the atrial natriuretic peptides in decreasing the number and DNA synthesis of human squamous lung cancer cells

1 reference

12 December 2020

Novel therapeutic approach for cancer using four cardiovascular hormones

1 reference

12 December 2020

Patient dosimetry for 131I-MIBG therapy for neuroendocrine tumours based on 123I-MIBG scans

1 reference

12 December 2020

Immunohistochemical identification of proliferating cells in organ culture using bromodeoxyuridine and a monoclonal antibody

1 reference

12 December 2020

Five cardiac hormones decrease the number of human small-cell lung cancer cells.

1 reference

12 December 2020

Four peptides decrease the number of human pancreatic adenocarcinoma cells

1 reference

12 December 2020

Four peptides decrease human colon adenocarcinoma cell number and DNA synthesis via cyclic GMP.

1 reference

12 December 2020

Four peptide hormones' specific decrease (up to 97%) of human prostate carcinoma cells

1 reference

12 December 2020

The N-terminus and a 4,000-MW peptide from the midportion of the N-terminus of the atrial natriuretic factor prohormone each circulate in humans and increase in congestive heart failure

1 reference

12 December 2020

Circulating immunoreactive proANP(1-30) and proANP(31-67) in sedentary subjects and athletes

1 reference

12 December 2020

Thyrotropin modulates receptors for atrial natriuretic peptide on intact human thyroid cells

1 reference

12 December 2020

Monoclonal antibody to 5-bromo- and 5-iododeoxyuridine: A new reagent for detection of DNA replication

1 reference

12 December 2020

Treatment of advanced medullary thyroid carcinoma with a combination of recombinant interferon alpha-2b and octreotide

1 reference

12 December 2020

Patterns of nodal metastases in palpable medullary thyroid carcinoma: recommendations for extent of node dissection

1 reference

12 December 2020

Four peptide hormones decrease the number of human breast adenocarcinoma cells.

1 reference

12 December 2020

Urodilatin and four cardiac hormones decrease human renal carcinoma cell numbers.

1 reference

12 December 2020

Immunocytochemical localization of atrial natriuretic peptide, vessel dilator, long-acting natriuretic peptide, and kaliuretic peptide in human pancreatic adenocarcinomas

1 reference

12 December 2020

Receptors for atrial natriuretic peptide (ANP) and regulation of thyroglobulin secretion by ANP in human thyroid cells

1 reference

12 December 2020

Medullary thyroid cancer: analyses of survival and prognostic factors and the role of radiation therapy in local control

1 reference

12 December 2020

Plasma concentration and urinary excretion of N-terminal proatrial natriuretic peptides in patients with kidney diseases

1 reference

12 December 2020

The role of radionuclide therapy in medullary thyroid cancer.

1 reference

12 December 2020

Negative feedback of atrial natriuretic peptides

1 reference

12 December 2020

Analysis of peptides derived from Pro Atrial Natriuretic Peptide that circulate in man and increase in heart disease

1 reference

12 December 2020

Atrial natriuretic peptide and long acting natriuretic peptide inhibit ERK 1/2 in prostate cancer cells.

1 reference

12 December 2020

Results of long-term continuous subcutaneous octreotide administration in 14 patients with medullary thyroid carcinoma

1 reference

12 December 2020

The assessment of cellular proliferation by immunohistochemistry: a review of currently available methods and their applications

1 reference

12 December 2020

10.1007/S12020-006-0011-6

Identifiers

DOI

1 reference

Dimensions Publication ID

17 September 2017

1018551595

0 references

1 reference